Zara and colleagues [31] observed increased phosphorylation of p38MAPK but no activation of other intracellular signalling pathways, such as ERK or Akt, after incorporation of PMPs in the highly aggressive breast cancer cell line MDA-MB-231 compared to the less aggressive MCF-7-cell line. The gene discussed is AKT1; the disease is breast carcinoma.